Ignite Creation Date:
2025-12-24 @ 2:31 PM
Ignite Modification Date:
2025-12-25 @ 8:11 PM
Study NCT ID:
NCT05630859
Status:
COMPLETED
Last Update Posted:
2025-08-07
First Post:
2022-11-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Efficacy of GSK Neisseria Gonorrhoeae GMMA (NgG) Investigational Vaccine When Administered to Healthy Adults 18 to 50 Years of Age.
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-11-28
Start Date Type:
ACTUAL
Primary Completion Date:
2025-05-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-05-22
Completion Date Type:
ACTUAL
First Submit Date:
2022-11-25
First Submit QC Date:
None
Study First Post Date:
2022-11-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-06
Last Update Post Date:
2025-08-07
Last Update Post Date Type:
ACTUAL